Rivian (NASDAQ: RIVN) stock has had a tough 2026. Shares have lost roughly 25% of their value since the year began But if you're willing to look beyond the past few months, the upside potential becomes clear. In fact, there's one catalyst in particular that could ma
What happened: Wolfspeed stock (WOLF) stock jumped more than 20% in premarket trading on Wednesday. What’s behind the move: Shares of the chipmaker soared after thematic research firm Citrini recommended the stock, highlighting it as “a crouching tiger getting ready to rev
Protara Therapeutics press release (TARA): Q1 GAAP EPS of -$0.31 beats by $0.06. - As of March 31, 2026, unrestricted cash and cash equivalents and marketable debt securities totaled $177.4 million. The Company expects its cash and cash equivalents and marketable debt secu
Billionaire Masayoshi Son’s megasize bet on OpenAI is powering profit at SoftBank Group. The Tokyo-based global tech investor recorded a gain of $25 billion on its stake in the ChatGPT maker in the first three months of the year, SoftBank said in its earnings report Wednes
Data center developer Nebius Group (NASDAQ: NBIS) said on Wednesday that first-quarter revenue rose 684% year over year to $399.0 million and that it secured up to 1.2 GW of power and land in Pennsylvania for a new owned AI factory. The AI cloud company reported net income
As the North American session gets underway, the US dollar is trading higher while equity markets are mostly firmer. Chip stocks are helping lead the gains after reports confirmed that Jensen Huang was traveling to China with President Trump and the US delegation Th
Palvella Therapeutics (PVLA) said Nasdaq approved the transfer of its common stock listing from the Nasdaq Capital Market to the Nasdaq Global Market, effective May 13. - The companyâs shares will continue trading under the ticker âPVLA.â - CEO Wes Kaupinen said
Protalix BioTherapeutics (AMEX:PLX) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzin
Intertek’s board recommends EQT’s £60 per share offer, valuing the UK testing firm at £10.6 billion including debt. EQT is set to acquire Intertek after the company’s board agreed to recommend a £60 per share cash offer, valuing the London-listed firm at £10.6 billion incl
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. - Truist Securities analyst William Stein upgraded Sensata Technologie